CELL REPROGRAMMING & THERAPEUTICS LLC
Biotech · Private
Multi-chamber hypoxic incubator system for controlled oxygen manipulation in stem cell reprogramming research
- Grants
- $725K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · New Cell Reprogramming Technology to Produce Dopaminergic Neurons | $199,999 | |
| Federal grant· 1 of 2 same day | National Science Foundation · Phase I · SBIR Phase I: Generation of Dopaminergic Neurons from Fat | $225,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Chemically produced neural progenitors loaded with ferumoxide-protamine sulfate complex for visualization of gliomas | $300,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2783 | Sensei Biotherapeutics, Inc. | — | $349M |
| 2784 | X4 Pharmaceuticals | — | $313M |
| 2785 | Nuvation Bio | — | $275M |
| 2786 | CELL REPROGRAMMING & THERAPEUTICS LLC | — | — |
| 2787 | Veradermics | — | $269M |
| 2788 | Avalyn Pharma | — | $242M |
| 2789 | Zylo Therapeutics Inc. | — | $4.9M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.